Skip to main content
ANTEROGEN CO., LTD. logo

ANTEROGEN CO., LTD. — Investor Relations & Filings

Ticker · 065660 ISIN · KR7065660003 KO Manufacturing
Open in API
Filings indexed 267 across all filing types
Latest filing 2023-02-28 Annual Report
Country KR South Korea
Listing KO 065660

About ANTEROGEN CO., LTD.

http://anterogen.com

ANTEROGEN CO., LTD. is a bio-venture company engaged in the research, development, and commercialization of cell therapy products and orphan drugs. The company specializes in utilizing adult stem cells, particularly adipose-derived mesenchymal stem cells, to create innovative treatments. Its key commercialized products include Cupistem®, an autologous stem cell therapy for Crohn's fistula, and Queencell®. Anterogen's research pipeline extends to applications for musculoskeletal diseases, spinal injuries, and cardiovascular conditions. The company also offers stem cell banking services.

Recent filings

Filing Released Lang Actions
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 23rd fiscal year (2022) of Anterogen Co., Ltd. It contains comprehensive information including company overview, history, capital changes, and detailed business descriptions, which is the standard format for an Annual Report in the Korean regulatory context (equivalent to a 10-K). FY 2022
2023-02-28 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Anterogen Co., Ltd. It contains the agenda for the upcoming annual general meeting, including the approval of financial statements, election of directors, and remuneration limits. It also includes detailed financial statements (balance sheet, income statement, cash flow, etc.) as part of the management's reference materials for the meeting. This type of document, which provides information to shareholders to request their votes for an upcoming meeting, is classified as a Proxy Solicitation & Information Statement.
2023-02-28 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and is a formal filing with the Korean regulatory body (Financial Supervisory Service/Korea Exchange). It contains specific details regarding the solicitation of proxies for an upcoming Annual General Meeting, including voting procedures, proxy information, and financial statements for the purpose of shareholder approval. This fits the definition of a Proxy Solicitation & Information Statement.
2023-02-28 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically an amendment ('정정신고') to a previous filing. It details changes to the number of recipients and the number of shares granted due to employee resignations. This type of disclosure regarding stock option grants and their subsequent amendments falls under general regulatory announcements for corporate actions that do not fit into specific categories like M&A or dividends, thus it is classified as a Regulatory Filing (RNS).
2023-02-24 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Anterogen Co., Ltd. It details the meeting date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and voting procedures (including electronic voting). This document is a standard proxy statement/notice sent to shareholders to solicit their participation and votes for the upcoming Annual General Meeting (AGM).
2023-02-22 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Statement), which is a formal document provided to shareholders to request their votes for an upcoming Annual General Meeting (AGM). It contains details about the meeting agenda, voting procedures, and proxy solicitation information. This falls under the category of Proxy Solicitation & Information Statement (PSI).
2023-02-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.